Key evidence of leadership capacity includes both qualitative and quantitative indicators. I have a long track record of bringing together effective scientific teams across national and disciplinary boundaries to address cutting-edge questions and a highly successful record of scientific production: 21,679 citations of more than 450 publications (≈44 citations/publication) and my h-index=67.
My multidisciplinary group explores the genetics of CV disease, collaborating in genome-wide association studies with MIGen project at The Broad Institute (Boston, MA) and currently in the study of epigenetic changes related to CAD. This research has led to the identification of new genetic characteristics related to myocardial infarction published in NEJM, Nature, and Nature Genetics, among others. This line of research has led to patents commercialized based on the improvement of reclassification of risk functions with CV genetic information.